Neonatal rebound hyperkalemia associated with ritodrine alone: a case report
Abstract Background Betamimetics have been used for tocolysis extensively in the past, and one of them, ritodrine is widely used in Japan. Various adverse events have been reported for this agent, including newborn hypoglycemia and hypokalemia, as well as maternal hypokalemia and rebound hyperkalemi...
Saved in:
Main Authors: | Keita Osumi (Author), Kenichi Suga (Author), Masashi Suzue (Author), Ryuji Nakagawa (Author), Shoji Kagami (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early-onset neonatal hyperkalemia associated with maternal hypermagnesemia: a case report
by: Kenichi Tanaka, et al.
Published: (2018) -
Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study
by: Shoko Shimokawa, et al.
Published: (2019) -
Ritodrine-Induced Agranulocytosis: A Case Report and Literature Review
by: Atsushi Daimon, et al.
Published: (2020) -
Hyperkalemia on ECG
by: Bryson Hicks
Published: (2016) -
Ritodrine-induced rhabdomyolysis and psychiatric symptoms: a case report and literature review
by: Li Sun, et al.
Published: (2023)